9: The "Disruptors" and the Role of Innovation in Drug Pricing

from Over the Counter · host Drug Topics

The Trump administration’s most recent executive order tackles drug pricing in the United States and replaces an order that was supposed to be implemented on August 24, 2020. In this podcast episode, Eric Levin, CEO of Scripta Insights, discusses with Drug Topics® how “positive disruption” from private companies and innovators are better positioned to confront challenges within the pharmaceutical industry.

Episode metadata supplied by the publisher feed · Published Sep 17, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

9: The "Disruptors" and the Role of Innovation in Drug Pricing

0:00 21:52

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Over the Counter?

This episode is 21 minutes long.

When was this Over the Counter episode published?

This episode was published on September 17, 2020.

Can I download this Over the Counter episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!